Description
Although a longstanding recommendation, the use of albumin as an effective treatment for patients with cirrhosis and ascites has come under scrutiny with recently published studies creating confusion.
This EASL Studio discusses, recent results from the MACHT, ATTIRE and PRECIOSA studies and try to shed some light on this controversial topic.
Faculty
- Prof. Alastair O’Brien (Moderator)
- Prof. Aleksander Krag (Moderator)
- Prof. Paolo Caraceni (Faculty)
- Dr Elisa Pose (Faculty)
- Prof. Joan Clària (Faculty)
ℹ️ Please click here to access the podcast version of this EASL Studio episode.
